Drugmakers and Insurers Attempt to Collaborate on Medication Prices

An increasing number of drugmakers, including Biogen Inc., Amgen Inc., and Sanofi are taking a proactive marketing approach–talking with insurers about costly medications still under development. With the price of these… Read More

Big Pharma and innovation

We were wondering if big pharmaceutical companies are adverse to the disruptive element of innovation. So, we asked our Zintro experts what they thought. Pradeep Oza, an expert in pharmaceutical… Read More